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A novel broad host range antimicrobial substance,
Thermophilin 13, has been isolated and purified from
the growth medium of Streptococcus thermophilus.
Thermophilin 13 is composed of the antibacterial pep-
tide ThmA (Mr of 5776) and the enhancing factor ThmB
(Mr of 3910); the latter peptide increased the activity of
ThmA ;40 3. Both peptides are encoded by a single
operon, and an equimolar ratio was optimal for Ther-
mophilin 13 activity. Despite the antilisterial activity of
Thermophilin 13, neither ThmA nor ThmB contain the
YGNGV-C consensus sequence of Listeria-active pep-
tides, and post-translational modifications comparable
to that in the lantibiotics are also absent. Mass spec-
trometry did reveal the apparent oxidation of methio-
nines in ThmA, which resulted in a peptide that could
not be enhanced any longer by ThmB, whereas the in-
trinsic bactericidal activity was normal. Thermophilin
13 dissipated the membrane potential and the pH gradi-
ent in liposomes, and this activity was independent of
membrane components from a sensitive strain (e.g. lipid
or proteinaceous receptor). Models of possible poration
complexes formed are proposed on the basis of sequence
comparisons, structure predictions, and the functional
analysis of Thermophilin 13.
Antibacterial membrane-acting peptides form a heterogene-
ous family of structures that can be subdivided in different
classes on the basis of primary sequence, mode of synthesis
(ribosomal versus non-ribosomal), post-translational modifica-
tions, and structure (linear, cyclic, a-helical, and b-sheet). The
following classes can be discriminated: (i) antibiotics (non-ribo-
somal synthesis, e.g. gramicidins (1)); (ii) lantibiotics (lanthi-
onine-containing peptides, e.g. Nisin (2)); (iii) host defense pep-
tides (3) of mammals (e.g. defensins), frogs (e.g. magainins),
and insects (e.g. cecropins). Some peptides have a strong he-
molytic activity in addition to antibacterial properties, like (iv)
bee venoms (e.g. melittin (4)) and (v) bacterial cytolysins (e.g.
Staphylococcus aureus d-toxin (5)). A particular class of anti-
bacterial peptides is formed by (vi) the bacteriocins (e.g. lacto-
coccins, Pediocins), which are produced by lactic acid bacteria
and preferentially inhibit species that are closely related to the
producer (6).
Besides their differences in structure and mode of membrane
interaction, antibacterial membrane-acting peptides may differ
in their requirement for specific lipids or proteins and/or mem-
brane potential or pH gradient to insert properly into target
membranes and/or to exhibit maximal activity. These require-
ments determine to a large extent the inhibitory spectrum of a
particular peptide. Moreover, in case of the lantibiotics and
bacteriocins, an immunity protein is synthesized that protects
the producer organism (7). Bacteriocins are often considered to
be different from other antibacterial membrane-acting peptides
by the fact that they require a proteinaceous membrane com-
ponent (i.e. receptor) for antibacterial activity, which is consist-
ent with their narrow host range specificity (6). A property of
some of the peptide bacteriocins is their ability to form poration
complexes that are composed of two different peptides (8, 9).
These bacteriocins have a very narrow inhibitory spectrum of
activity (6). Finally, the so-called Listeria-active bacteriocins
share a consensus sequence motif (YGNGV-C) at their amino
terminus (9) which could be of importance for their ability to
inhibit Listeria species. The “Listeria-active bacteriocins” have
not been reported to form poration complexes.
In this article, we describe the properties of a broad host
range pore-forming antimicrobial activity, named Thermophi-
lin 13. The compound has structural and functional features of
bacteriocins, in particular those that form poration complexes.
However, none of the two peptides of Thermophilin 13 owes the
antilisterial YGNGV-C consensus sequence and a proteina-
ceous receptor is not required for activity. We also present a
model of the poration complex formed by Thermophilin 13 on
the basis of structural similarities with host defense peptides
and other pore-forming structures.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Media—The bacteriocin producer Streptococ-
cus thermophilus SFi13 as well as the indicator micro-organisms are
from the Nestle´ strain collection. The indicator strain used to assess the
bacteriocin concentration (activity) during purification was S. ther-
mophilus SFi3. Lactococcus, Streptococcus, and Enterococcus strains
were grown semi-anaerobically in M17 broth (Oxoid, U K) supple-
mented with 0.5% (w/v) glucose at 30, 42, and 30 °C, respectively.
Lactobacillus, Pediococcus, Leuconostoc, and Bifidobacteria strains
were grown in MRS, 0.5% (w/v) glucose (Sanofi Diagnostics Pasteur,
France) at 30 °C except for the thermophilic Lactobacilli (42 °C) and
Bifidobacterium (37 °C). Clostridium strains (spores and vegetative
cells) were grown in RCM (Oxoid) at 30 °C under an atmosphere of 85%
(v/v) N2, 5% CO2, 10% H2. Bacillus (30 °C), Listeria (30 °C), Micrococcus
(30 °C), Staphylococcus (30 °C), Salmonella (37 °C), and Escherichia
coli strains (37 °C) were all grown in BHI (Difco) at the temperatures
indicated. E. coli BZ234 (C600 derivative allowing a-complementation;
Biozentrum, University of Basel, Switzerland) was grown in Luria
broth (10).
Production and Concentration of Thermophilin 13—S. thermophilus
SFi13 was grown semi-anaerobically at 42 °C in 1 liter of M17 supple-
mented with 1% (w/v) sucrose (M17S, M17 broth (Oxoid) supplemented
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with 1% (w/v) sucrose) until 2 h into the stationary phase. Cells were
removed by centrifugation (20,000 3 g for 20 min), and the pH was
adjusted to 1.6 by phosphoric acid. Insoluble material was removed by
centrifugation (20,000 3 g for 20 min at 4 °C), and the soluble fraction,
containing the antibacterial activity, was concentrated by trichloroace-
tic acid precipitation (trichloroacetic acid, 10% (w/v) final). The pellet
was washed twice with cold acetone (220 °C), resuspended in 8 ml of
0.1% trifluoroacetic acid, and heated for 20 min in boiling water. Insol-
uble material was removed by centrifugation; the soluble sample ob-
tained was termed trichloroacetic acid extract.
Bacteriocin Assays—The bacteriocin activity was measured in an
agar well assay. Briefly, 5 ml of M17S Top-Agar (0.75% (w/v)) were
mixed with 20 ml of an overnight culture of the indicator strain SFi3 and
poured on top of 35 ml of M17S-Agar (1.5% (w/v)). Wells of 70 ml were
made using a 3.5-mm diameter punch-holer connected to a vacuum
device, and serial dilutions of the sample were assayed in different
wells. Consequently, the highest dilution still showing activity defines
the activity of the 70-ml aliquot in terms of arbitrary units (AU).1 The
amount of Thermophilin 13 in a given volume (V ml) was expressed in
total units (U 5 (AU/70) 3 V). The concentration of Thermophilin 13
was defined as AU/ml 5 AU/70 3 1000.
Purification of Thermophilin 13 and Identification of ThmA and
ThmB—The trichloroacetic acid pellet of a 1-liter culture was dissolved
in 8 ml of 200 mM Tris-HCl, pH 8.0, 6 M urea plus 2 M NaCl and used for
purification on a 20-ml Source 15-Phe resin (15-Phe) packed into a
HR16/10 column (Pharmacia Biotech Inc.). Flow rates were kept con-
stant at 4 ml/min. The column was first washed with 100 ml of 50 mM
Tris-HCl, pH 8.0, 2 M NaCl (buffer A) before applying a 60-ml linear
gradient of buffer A to buffer B (50 mM Tris-HCl, pH 8.0), which was
followed by 150 ml of buffer B and 100 ml of H2O. Thermophilin 13 was
eluted with 60 ml of buffer C (70% (v/v) acetonitrile, 30% (v/v) water,
and 0.1% (v/v) trifluoroacetic acid). 20 ml of 100% methanol were added
to the active fractions (;40 ml total), and the volume was reduced to 24
ml by rotary evaporation (approximately 50% (v/v) methanol, final
concentration). This sample was applied to a 3-ml Resource RP column
(RPC, Pharmacia, NL), previously equilibrated with 50% (v/v) metha-
nol, 50% water, 0.1% trifluoroacetic acid (buffer E). A flow rate of 2
ml/min was kept throughout the procedure. After washing with 100 ml
of buffer E at a flow rate of 2 ml/min, a linear gradient from buffer E to
100% acetonitrile (in 0.1% trifluoroacetic acid) was applied in 30 min.
Two main peaks were characterized by electrospray-MS and re-chro-
matographed separately after dilution (1:1) in 0.1% trifluoroacetic acid.
Both peaks were collected from two independent runs, re-analyzed by
electrospray-MS, and stored at 220 °C in their elution solvent.
Mass Spectrometry—Electrospray mass spectra were recorded on a R
3010 quadrupole mass spectrometer (NERMAG, Argenteuil, France)
equipped with a custom-built pneumatically assisted electrospray (ion
spray) ion source. The molecular weight of the peptides is determined
by measurement of multiply charged ions (11). All molecular masses
quoted in this paper are average, chemical atomic masses.
Inhibitory Spectrum—Multiwell dishes (Falcon 3046) were filled
with 6 ml of Agar medium per dish and 0.7 ml of Top-Agar were
inoculated with 0.1–1% of an overnight culture or 105 spores/ml of
Top-Agar. Each strain was tested with 300 AU of Thermophilin 13
which was obtained after dilution of the trichloroacetic acid extract with
100 mM potassium phosphate, pH 7.0. A control of bacteriocin activity
was included for each strain using a proteinase K-treated sample (5
mg/ml at 37 °C for 20 min). Minimum inhibitory concentration values
were estimated from the size of the halos obtained with the trichloro-
acetic acid extract; the data were calibrated on the basis of the inhibi-
tion of S. thermophilus SFi3 strain (1 AU 5 11 nM). This method was
validated for Clostridium botulinum, Listeria monocytogenes, Lactococ-
cus lactis, Bacillus cereus, Bacillus subtilis and S. thermophilus, using
purified Thermophilin 13 (equimolar ratio of ThmA and ThmB).
Protein Determination—Protein concentrations were determined by
the method of Lowry et al. (12), with bovine serum albumin as standard,
unless indicated otherwise.
DNA Preparations—General procedures for DNA isolation from E.
coli, restriction analysis, ligation, electrophoresis, Southern analysis,
and colony hybridization were carried out as described previously (10).
For preparation of genomic DNA from S. thermophilus, cells were
grown in 2 ml of M17S until the mid-log phase, treated with lysosyme
(13), and resuspended in 2 ml of STE (25% (w/v) sucrose, 50 mM
Tris-HCl, pH 8.0, 1 mM EDTA). SDS and RNase A were added to final
concentrations of 1% (w/v) and 50 mg/ml, respectively, and the mixture
was incubated for 1 h at 37 °C. Subsequently, proteinase K was added
to a final concentration of 100 mg/ml, and the mixture was incubated for
2 h at 55 °C. DNA fibers were spooled in 70% ethanol, solubilized
overnight in TE, and extracted with chloroform (10).
Cloning of the Bacteriocin Encoding Genes—A set of degenerate
oligonucleotides was deduced from the 48 amino acid amino-terminal
sequence of ThmA. The forward primer corresponded to 59GAYAT-
GGGNGGNTAYGC39 (For1) and the reverse primers corresponded to
39GTACANCCNCGNTAACG59 (Rev1), 39GTACANCCNCGNTAGCG-
59(Rev2), 39GTACANCCNCGNTATCG59(Rev3), 39GTGCANCCNCG-
NTAACG59(Rev4), 39GTGCANCCNCGNTAGCG59(Rev5), and 39GTG-
CANCCNCGNTATCG59(Rev6). Primers and chromosomal DNA were
used at final concentrations of 5 mM and 1.3 mg/ml, respectively. Other
components were added as specified in the polymerase chain reaction
protocol using SuperTaq polymerase of Boehringer Mannheim, and a
5-min denaturation cycle at 95 °C was followed by 30 cycles of 30 s
95 °C, 30 s 42 °C, and 30 s 72 °C; elongation was achieved by a final
5-min step at 72 °C. Polymerase chain reaction fragments of the ex-
pected size (128 bp) were eluted, ligated into plasmid pGEM-T (Pro-
mega, CH), and propagated in E. coli BZ234. The 128-bp fragment was
used as a hybridization probe (primer extension, Boehringer Mann-
heim) to identify and clone a 3.8-kb EcoRI-HindIII genomic DNA frag-
ment that carried the genes for ThmA and ThmB. Recombinant strains
of E. coli BZ234 were identified by colony hybridization using the
128-bp probe on Zeta-probe membranes (Bio-Rad) (10).
Computer Analysis—Multiple sequence alignments, data base
searching, and structure prediction methods were used from the GCG
package (Genetics Computer Group, Inc.), PCGENE and the EMBL
worldwide web servers (PredictProtein@EMBL-Heidelberg.DE). Hair-
pin turns were accepted when the conformational potential for each
residue of the tetrapeptide to be in turn ,pt. is higher than ,pa. and
,pb. (14), and the probability of forming a b-turn by a tetrapeptide
was p(t)1024 . 2 (15).
Membrane Preparations—Right-side out membrane vesicles of S.
thermophilus and their fusion to cytochrome c oxidase containing lipo-
somes (COVs) were performed in 50 mM potassium phosphate, pH 7.0,
as described previously (16).
Measurement of Membrane Potential (DC) and pH Gradient (DpH)—
The membrane potential (DC) was estimated from the distribution of
tetraphenylphosphonium ion (TPP1) using an ion-selective electrode
(17). COVs or hybrid membranes were diluted into 50 mM potassium
phosphate, pH 6.3, plus 5 mM MgSO4, (saturated with oxygen) to a final
concentration of 153 nM in cytochrome c oxidase. A proton motive force
was generated in COVs or hybrid membranes by adding the electron
donor system ascorbate (10 mM), TMPD (200 mM) plus cytochrome c (10
mM), and oxygen (18). The DC was calculated after correction for probe
binding to the membrane (19) and using a specific internal volume of 1.5
ml/mg lipids (20). The pH gradient was monitored by the fluorescent pH
indicator pyranine (21). Pyranine was entrapped in the COVs by freeze/
thaw/sonication as described previously (18), and external pyranine
was removed by gel filtration on Sephadex G25. Pyranine-containing
COVs were diluted into 50 mM potassium phosphate, pH 6.3, plus 5 mM
MgSO4 (saturated with oxygen), to a final concentration of 46 nM in
cytochrome c oxidase, and DpH was estimated from the changes in
pyranine fluorescence.
Cytochrome c Oxidase Activity—Cytochrome c oxidase activity was
measured in liposomes by monitoring the decrease in absorbance at
550–540 nm (a-peak) (22) in the presence and absence of Thermophilin
13. The reaction was performed in 50 mM potassium phosphate, pH 6.3,
plus 5 mM MgSO4 (saturated with oxygen), at a final concentration of 16
nM in cytochrome c oxidase and in the presence of 60 nM valinomycin
plus 60 nM nigericin.
RESULTS
Purification of Thermophilin 13—S. thermophilus SFi13 pro-
duced 570 AU/ml of Thermophilin 13 when grown in M17S and
harvested after 2 h in the stationary phase. Clarification of the
medium supernatant by phosphoric acid resulted in the re-
moval of exo-polysaccharides as well as 99% (w/w) of proteins
(Table I); the increase in activity after trichloroacetic acid pre-
cipitation could be assigned to the decrease in pH as the activ-
1 The abbreviations used are: AU, arbitrary units; MS, mass spec-
trometry; RPC, reverse phase chromatography; 15-Phe, Source 15-Phe
reverse phase column HR16/10; Resource-RPC, resource reverse phase
column; COVs, cytochrome c oxidase-containing liposomes; TPP1, tet-
raphenylphosphonium ion; bp, base pair(s); kb, kilobase pair(s); ORF,
open reading frames.
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ity of Thermophilin 13 increases 4-fold when the pH is lowered
from 8.0 to 2.0 (data not shown). Also, variations in activity
throughout the purification can be ascribed to a loss of Ther-
mophilin 13, variations in pH, or changes in aggregation states
(i.e. solubilization) of the bacteriocin. Thermophilin 13 was
purified further on a Source 15-Phe resin, which eliminated
93% of the remaining contaminants (Table I). An activity of 113
AU/ml was obtained after the Resource-RPC for the fractions
eluting between 17.5 and 19 min; a much higher activity was
obtained when these fractions were mixed with those eluting
between 21 and 24 min. Both sets of fractions were re-chro-
matographed independently on the Resource-RPC and ana-
lyzed by electrospray MS (Fig. 1). A Mr of 5776 was determined
for the fractions eluting between 17.5 and 19 min, and two
molecular weights were found for the fractions eluting between
21 and 24 min (Fig. 1). These latter two compounds were
named ThmB (Mr of 3910) and ThmB9 (Mr of 3892). As shown
in Table I, the Resource-RPC eliminated 94% of the remaining
contaminating proteins but resulted in a decrease in total ac-
tivity from 220 to 27 kU. The apparent loss in activity is partly
due to the fact that only peak fractions, which were pure by
electrospray-MS criteria, were used in the calculation of the
activity. It should also be stressed that the concentration of the
purified peptides was estimated from their absorbance at 280
nm, using extinction coefficients of 1490 and 5500 M21 cm21 for
Tyr and Trp, respectively (23), rather than the Lowry assay
(12) which was used throughout the purification procedure.
Antibacterial Properties of ThmA and ThmB on S. ther-
mophilus SFi3—As already suggested by the experiments pre-
sented above, fractions containing ThmB seem to enhance the
activity of ThmA. The enhancing properties of ThmB are
clearly shown in Fig. 2 (left panel), i.e. the diameter of inhibi-
tion of growth by ThmA is increased in the presence of ThmB
(top left panel). The activity of 2.2 mM ThmA was 20 AU (top left
panel), whereas the activity of 1.1 mM ThmA plus 1.1 mM ThmB
was 400 AU. In other words, the activity of ThmA is enhanced
40-fold in the presence of an equimolar concentration of ThmB.
The antibacterial activity at different concentrations and ratios
is presented in Fig. 3. Surfaces of the inhibition zones were
plotted as a function of ThmA and ThmB concentration in the
range of 0 to 2.2 mM (0–155 pmol/well). The largest inhibition
zones were observed at the diagonal connecting equimolar con-
centration of ThmA and ThmB (Fig. 3A), and the minimum
inhibitory concentration value of Thermophilin 13 was esti-
mated to be 11 nM for S. thermophilus SFi3 as indicator strain
(Fig. 3C). In Fig. 3B, the antibacterial activity of Thermophilin
13 is shown at high amounts of ThmA relative to ThmB. It
appeared that 1100 nM ThmA has the same activity as 27 nM of
ThmA plus 27 nM ThmB (Fig. 3B). Fig. 3C shows that ThmB
has no intrinsic activity even at high concentrations (2200 nM),
and Fig. 3D shows that a large excess of ThmB over ThmA
inhibits the activity of the latter peptide.
Inhibitory Spectrum of Thermophilin 13—Cells or spores
were mixed with Top-Agar and poured on top of agar medium
to obtain a homogeneous lawn. Prior to growth, wells were
made in which diluted, neutralized trichloroacetic acid extract
or purified ThmA and/or ThmB were introduced; proteinase
K-treated samples were used as negative controls. The results
obtained with the neutralized extract were similar to those of
ThmA plus ThmB, indicating that a single bacteriocin is pro-
duced by S. thermophilus SFi13 under the conditions tested.
Diameters of inhibition surrounding the wells were measured
after overnight growth. As for other peptide bacteriocins, a
narrow inhibitory spectrum was expected for Thermophilin 13
(6, 9). Thermophilin 13, however, exerted a broad host range
activity among Gram-positive bacteria (Table II). Not only lac-
tic acid bacteria were affected, but also L. monocytogenes and
FIG. 1. Elution profile after reverse phase chromatography
(Resource-RPC). Fractions obtained after phenyl interaction chroma-
tography (24 ml; Source 15-Phe resin) were applied to the Resource-
RPC at a flow rate of 2 ml/min in buffer A (methanol 50% (v/v), water
50%, trifluoroacetic acid 0.1%). Elution was performed with a linear
gradient at 2 ml/min in 30 min from buffer A to B (100% CH3CN,
trifluoroacetic acid 0.1% (v/v)), and two peaks were re-chromatographed
separately as indicated in the text; their elution profiles are presented
here. Molecular weights (Mr) of the peak fractions are indicated. RT,
retention time.
FIG. 2. Antibacterial properties of ThmA, ThmB and ThmA*.
Top left panel, activity of ThmA (A2 and A20) and ThmB (B2 and B20)
were evaluated with the agar well assay at dilutions of 2- and 20-fold.
Dilution 2 corresponds to 2.2 mM, i.e. 154 pmol/well. Bottom left panel,
activity of ThmA was assessed in the presence of equimolar amounts of
ThmB at dilutions of 20-, 200-, and 400-fold. Right panels, the same
experiments were performed with ThmA9 instead of ThmA.
TABLE I
Purification of Thermophilin 13
Steps Volume pH Total activity Protein amounta Specific activity
ml kU mg kU/mg
Supernatant 1000 4.7 570 7000 0.08
Trichloroacetic acid extract 8 2.0 940 42 22.4
Source 15-Phe 40 8.0 220 3 76
Resource-RPC 6 2.0 27b 0.17 159
a According to Lowry et al. (15) except for the Resource-RPC, for which the absorbance at 280 nm of each purified peptide was used.
b Only peak fractions were considered (see text).
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spore-forming micro-organisms like C. botulinum and B.
cereus. Interestingly, growth from spores as well as from veg-
etative cells was inhibited. Bacterial genera most related to the
producer (e.g. streptococci, enterococci, lactococci, lactobacilli)
were inhibited to the same extent as more distantly related
organisms (e.g. bacilli, clostridiae). All Gram-negative bacteria
tested (E. coli, Pseudomonas and Salmonella species) were
resistant. ThmA alone had an intrinsic activity that was en-
hanced by ThmB on all strains tested.
Genetic Organization of the Bacteriocin Operon—Amino-ter-
minal sequences of ThmA and ThmB were determined (initial
yield of 1150 and 1160 pmol, respectively). Oligonucleotide
primers were designed on the basis of the amino-terminal
sequence of ThmA (48 residues): YSGKDXLKDMGGYAL-
AGAGSGALXGAPAGXVGALPGAFVGAHVGAIAG. The se-
quences DMGGYA and HVGAIA were used to design the for-
ward (For1) and six different reverse primers (Rev1–6),
respectively. The expected 128-bp fragment was obtained in a
FIG. 4. Nucleotide sequence and deduced polypeptide se-
quences of the Thermophilin 13 gene cluster. The 960-bp DNA
sequence localized 1600 bp downstream of the EcoRI site of the cloned
3.8-kb HindIII-EcoRI fragment is shown. The structural genes of Ther-
mophilin 13 (thmA and thmB) together with their signal sequences
(underlined) are depicted below the nucleotide sequence. The GG-proc-
essing sites are indicated by bold triangles. ORFC is a third peptide,
encoded by the Thermophilin 13 operon. Putative promoter sequences,
ribosome binding sites (RBS), start and stop codons, and rho-indepen-
dent terminator sequences are indicated in bold.
TABLE III
Molecular weights (Mr) of the purified peptides deduced from those of













/5 Mr 1/2 1
ThmA 1926 1445 1156 5776
1926 1445 1156 5776
ThmA9 1931 1449 1159 5792
1936 1453 1162 5808
ThmB 1956 1304 3910
ThmB9 1948 1298 974 3892
FIG. 3. Antibacterial properties of ThmA and ThmB. Vertical
axis, surface inhibition in the agar well assay in mm2; horizontal axis,
concentrations of ThmA and ThmB expressed in nM. A, equimolar ratios
of ThmA and ThmB; B, excess of ThmA; C, excess of ThmB; D, excess of
ThmB at high concentrations of ThmA.
TABLE II
Inhibitory spectrum of Thermophilin 13
Species Strainsa Diameter ofinhibitionb MIC
c
mm nM
S. thermophilus SFi3 13.5 11
Enterococcus faecium SFM1 10 413
Lactococcus cremoris SC11 10 413
Lactobacillus acidophilus LQ1 9.5 470
Lactobacillus helveticus LH3 13.5 11
Lactobacillus fermentum L26 10.5 206




Bifidobacterium bifidum BB9 15.5 5
Propionibacterium PP1 13 17
Listeria innocua 24 6.5 1885
L. monocytogenes 59 10.5 206
B. subtilis A2 7.5 1650
B. cereus C14 12 69




Staphylococcus carnosus STC7 8 1100
Micrococcus varians MCV1 8 1100
a All strains are from the Nestle´ strain collection.
b Diameter of inhibition observed with 300 AU of Thermophilin 13.
c Minimum inhibitory concentration, to observe a halo in the Agar
well assay.
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polymerase chain reaction with the primers For1 and Rev1
using SFi13 genomic DNA as template. The 128-bp probe hy-
bridized to a 4.2-kb HindIII and a 3.8 HindIII-EcoRI fragment
in the producer strain SFi13; these fragments were not de-
tected by hybridization in the non-producer sensitive SFi3
strain. Subsequently, SFi13 chromosomal HindIII-EcoRI DNA
fragments of 3.6–4 kb were ligated into pUC19, and the re-
combinant plasmids were transformed to E. coli BZ234. Colony
hybridization identified 16 putative positive colonies, among a
total of 250, containing a 3.7-kb HindIII-EcoRI insert that was
sequenced and searched for open reading frames (ORFs) (Fig.
4). Two ORFs corresponding to ThmA and ThmB were found.
Both peptides are synthesized with a signal sequence typical of
lactic acid bacteria peptide bacteriocins, i.e. the processing site
is preceded by a double glycine motif. The calculated molecular
masses of ThmA and ThmB are 5776.7 and 3910.5 Da, respec-
tively. The translation of ThmB is most likely coupled to that of
a 52-amino acid hydrophobic peptide, termed ORFC; no homo-
logue of ORFC was found in the data bases. Putative promoter
elements, ribosome binding sites, and a rho-independent ter-
minator structure were found in the regions flanking the ORFs
(Fig. 4).
Chemical Modifications of ThmA and ThmB—Genetic anal-
ysis of ThmA and ThmB showed the presence of two cysteines
in each peptide. Since Thermophilin 13 was fully active in the
presence of 50 mM dithiothreitol, using the agar well assay,
disulfide bonds are most likely not required for activity. The
calculated average molecular masses of ThmA (5776.7 Da) and
ThmB (3910.5) are consistent with the masses obtained after
purification on Resource-RPC, i.e. 5776 6 1 and 3910 6 1 Da,
respectively (Table III). However, a peak shoulder was noticed
upon re-chromatography of ThmB on Resource-RPC (Fig. 1).
MS analysis revealed a mass of 3892 Da in the shoulder (Table
III), which is ;18 Da lower than that calculated from the
translated nucleotide sequence of ThmB. This reduction in
mass also occurred in the synthesized peptide ThmB upon
prolonged storage but did not affect the enhancing properties of
ThmB (purified or synthesized). Electrospray-MS also revealed
FIG. 5. In vitro pore-forming activ-
ity of Thermophilin 13. A, cytochrome c
oxidase-containing proteoliposomes were
fused to membrane vesicles of the sensi-
tive SFi3 strain and used at a final lipid
concentration of 0.2 mg/ml. TPP1 (4 mM),
ascorbate (Asc., 10 mM), TMPD (200 mM),
cytochrome c (Cyt c, 10 mM), and nigericin
(NIG, 100 nM) were added as indicated.
Thermophilin 13 was added to final con-
centrations of 1.8, 3.6, 7.15, and 14.3 nM,
and the obtained DC values for each con-
centration are indicated. Valinomycin
(VAL) was added to a final concentration
of 200 nM. B, effect of Thermophilin 13 on
the DC in cytochrome c oxidase liposomes
(COVs); conditions were the same as for
A. C, effect of Thermophilin 13 on the
internal pH in COVs. Experimental con-
ditions were the same as in B except that
pyranine (0.5 mM, internal concentration)
was entrapped in the liposomes. The
amounts of ThmA plus ThmB (4.4, 13.2,
or 44 nM, each) are indicated. Nisin was
added at final concentrations of 1.5, 3.0,
and 4.5 mM, respectively (subsequent ad-
ditions of 1.5 mM).
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chemical modifications in ThmA; the modified product was
termed ThmA9. Comparison of the MS spectra of ThmA and
ThmA9 shows two additional peaks for each multiply proto-
nated species, leading to triplets for the ions with 3, 4, and 5
charges (Mr 1 3H
1, Mr 1 4H
1, or Mr 1 5H
1) (Table III). These
data indicate that ThmA9 has gained one or two times 16 Da
(average of 3 3 5, 4 3 4, and 5 3 3 Da), which corresponds to
the gain of one or two oxygen atoms and suggests that ThmA
becomes oxidized upon storage. Although ThmA9 was as active
as ThmA (Fig. 2, right panel, top part), the activity of ThmA9
was no longer enhanced by ThmB (Fig. 2, right panel, lower
part). Oxidation of ThmA to ThmA9 could be prevented by
storage at 220 °C. Neither ThmA nor ThmB contain post-
translational modifications common to those of lantibiotics or
cystibiotics like Pediocin PA-I (6). In the experiments described
below, Thermophilin 13 refers to an equimolar ratio between
ThmA (non-oxidized) and ThmB (both forms).
In Vitro Pore-forming Activity of Thermophilin 13—The po-
ration complex bacteriocins have a narrow host range specific-
ity and require a “receptor” for pore-forming activity (7). The
poration complex bacteriocins function in membrane vesicles
derived from sensitive species but not in (proteo)liposomes,
with the exception of Lactococcin G, which is only active in
whole cells (24). Thermophilin 13, on the other hand, affects a
large variety of organisms (Table II), suggesting that it might
not require a specific factor to exert its bactericidal activity. To
investigate whether Thermophilin 13 exerted a pore-forming
activity in target membranes, we studied the ability of the
bacteriocin to dissipate the membrane potential (DC) in cyto-
chrome c oxidase containing liposomes (COVs) fused with
membranes of the sensitive S. thermophilus strain SFi3. In the
presence of the electron donor system potassium ascorbate/
TMPD/cytochrome c, a DC (inside negative) and a DpH (inside
alkaline) was generated. To clamp the DpH to 0, nigericin was
present in the measurements of DC. Increasing amounts of
purified Thermophilin 13 dissipated the DC progressively (Fig.
5A). To establish the influence of membrane proteins and/or
lipids of the target organism on this putative pore-forming
activity, the bacteriocin was also tested on COVs solely com-
posed of E. coli lipids plus egg phosphatidylcholine at a molar
ratio of 3 to 1. Thermophilin 13 also dissipated the DC in COVs
(Fig. 5B). ThmA alone had little effect, and ThmB alone had no
effect on the DC both in the hybrid membranes and COVs (data
not shown). To investigate the activity of Thermophilin 13 in
the absence of a membrane potential, the effect of Thermophi-
lin 13 on the pH gradient in COVs was analyzed. Valinomycin
was used to keep DC at zero, and the COVs were loaded with
the pH indicator pyranine. It appeared that Thermophilin 13
was able to dissipate the DpH at nanomolar concentrations,
whereas similar concentrations of ThmA and ThmB alone had
virtually no effect (Fig. 5C). Nisin had only little effect on the
DpH in the COVs at micromolar concentrations.
Effect of Thermophilin 13 on the Cytochrome c Oxidase Ac-
tivity—It was possible that Thermophilin 13 dissipated the DC
and DpH by inhibiting cytochrome c oxidase activity. Up to a
concentration of 100 nM, we observed no effect on cytochrome c
oxidase activity reconstituted in liposomes; the measurements
were performed in the presence of nigericin plus valinomycin to
prevent increases in oxidase activity due to respiratory control.
Overall, these results suggest that Thermophilin 13 is able to
dissipate DC in the absence of DpH and to dissipate DpH in the
absence of DC, without the need for a specific proteinaceous
receptor or lipids from a sensitive host strain.
FIG. 6. Sequence comparison of poration complexes and Listeria-active peptides. Sequences were aligned by PileUp (GCG package). In
addition to the Listeria-active peptides, the poration complex bacteriocins are classified as Class E (for enhancing) and Class S (for synergy).
Hydrophilic residues are shown in red; shaded boxes symbolize identity within a family. Tetrapeptides predicted to be in a b-turn conformation (p(t)
3 1024 . 1.5 (14, 15)) are printed in dark blue. Consensus in secondary structures predictions are indicated in blue, for each class of peptides: *,
A, T, and H refer to hydrophilic (non-transmembrane segment), amphipathic a-helix, hairpin turn, and hydrophobic (a-helix or b-sheet)
transmembrane segment, respectively.
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DISCUSSION
In this paper, we describe a novel antimicrobial compound,
Thermophilin 13, which differs from other known bacteriocins
in its structural and/or functional properties. (i) Thermophilin
13 exerts an activity in COVs which so far has only been
observed for bacteriocins of the lantibiotic type; (ii) Thermophi-
lin 13 has antilisterial activity but lacks the YGNGV-C motif,
typical of the Listeria-active peptides; (iii) Thermophilin 13
forms a poration complex but in contrast to other “two-compo-
nent bacteriocins” it has a broad host range activity.
The experiments in COVs, prepared from E. coli/egg phos-
phatidylcholine lipids (Fig. 5), indicate that Thermophilin 13
does not need a specific component (proteinaceous or lipid) in
the membrane for activity. It should be stressed that, although
a receptor has not yet been identified for any lactic acid bacte-
rial bacteriocin, the “non-lantibiotics” require an “additional
factor” in the target membrane to exert pore-forming activity
(6, 25). In fact, only lantibiotics, and bacteriocins thought to
contain lanthionines (e.g. Plantaricin C), have so far been
shown to exert pore-forming activity in COVs (2, 26, 27). Fur-
thermore, and in contrast to the lantibiotics (2), Thermophilin
13 does not require a threshold membrane potential to dissi-
pate the pH gradient (Fig. 5C) or a threshold pH gradient to
dissipate the membrane potential (Fig. 5B).
The experiments also established that Thermophilin 13
forms a poration complex that is composed of an equimolar
ratio of the two peptides ThmA and ThmB (Fig. 3A). ThmA
alone has antibacterial activity against S. thermophilus, C.
botulinum, L. monocytogenes, and B. cereus, which is enhanced
;40-fold when an equal amount of ThmB is present. ThmB, by
itself, is not bactericidal, and an excess of this peptide inhibits
the activity of ThmA (Fig. 3D), possibly because it destabilizes
the pore leading to dysfunctional oligomeric structures. By
comparison, Lactacin F (28), and Plantaricin S (29) are also
composed of an active and enhancing peptide, whereas the two
peptides of Lactococcin G have virtually no activity when tested
separately, i.e. 5 3 105 times less than when used in combina-
tion (24). These considerations have led us to subdivide the
poration complex bacteriocins into two classes: type E, for
Enhancing, i.e. when one of the peptides only functions as an
enhancer as for Thermophilin 13, Lactacin F and Plantaricin S,
and type S, for Synergy, i.e. when activity is believed to require
the combination of both peptides, e.g. Lactococcin G (24) and
Plantaricin A (30). Interestingly, this functional classification
is substantiated by similarities in primary sequence and pre-
dicted secondary structure of the peptides (Fig. 6). Type E
peptides are characterized by several G(A/G)G repeats and are
predicted to form an amino-terminal amphipathic a-helix fol-
lowed by a hydrophobic anchor. On the basis of these criteria,
Lactococcin M (31) and Curvaticin FS47 (32) were classified as
type E peptides (Fig. 6). The amino-terminal amphipathic a-he-
lix of ThmA could be stabilized by a salt bridge between Asp5
and Lys8 and by hydrogen bonding between the amino- and
carboxyl-terminal parts (Fig. 7A). By contrast to other type E
peptides, three b-turns are predicted in the sequence of ThmB,
at distances that allow the intervening sequences to span the
membrane as antiparallel b-sheets (Fig. 6); the presence of
helix-breaking residues (serines and asparagines) and the pre-
diction of two amphipathic strands further support a b-sheet
conformation for ThmB. Type S peptides are characterized by
an amphipathic a-helix composed of charged residues at one
face of the helix and highly hydrophobic residues at the oppo-
site face (Fig. 6). On the basis of structural similarities with
Lactococcin G (8) and Plantaricin A (30), Plantaricin E, F, J,
and K (33) have been placed into class S peptides (Fig. 6) even
though experimental evidence that these bacteriocins form
similar poration complexes is lacking.
High probabilities of hairpin turns are not only found in
ThmB but also in ThmA, in the Listeria-active peptides (see
Ref. 6 for review), and downstream of the amphipathic a-helix
of the partially sequenced peptide Curvaticin FS47 (32) (Fig. 6).
Since Thermophilin 13 and Curvaticin FS47 have been shown
to exert antilisterial activity, we speculate that the hairpin
turn might be one of the critical elements of the GG-processed
peptides to exert antilisterial activity. In this respect, it is
worth emphasizing that the membranes of Listeria species
differ significantly from that of lactic acid bacteria, not only in
lipid conjugates (e.g. lipoteichoic acids), apolar lipids (e.g. iso-
prenoid quinones), but also in fatty acids (34).
The sequence analysis has been used to derive a structure
model for the poration complexes formed by ThmA (plus
ThmB). The intrinsic activity observed for ThmA and ThmA9
can be explained by oligomerization of the peptide to form the
structure ((A)n) (Fig. 7). The MS analysis of ThmA9 strongly
suggests oxidation of methionines to methoxides (Met10, Met54,
and/or Met57; yellow circles in Fig. 7), which would not dramat-
ically influence the pore-structure as shown in Fig. 7, (A)n, but
would disturb the interactions between ThmA and ThmB (Fig.
FIG. 7. Structure models of the poration complex formed by
Thermophilin 13. Secondary structure models of ThmA (A), ThmB
(B), and top view models of the pores formed by ThmA (A)n, and ThmA
plus ThmB (AB)n (i.e. Thermophilin 13) are shown. Cationic residues
(K, R, and H) are represented in red; anionic residues (D and E) are
indicated in blue, hydrophilic amino acids (S, T, N, and Q) are depicted
in purple. Methionine residues (Met10, Met54, and Met57) likely to form
methoxides are indicated in yellow. Tetrapeptides predicted to form
b-turns of p(t) 3 1024 . 1.5 (14, 15) are depicted in green. In the top
view models, helices are represented by circles, and two b-strands are
symbolized by a square.
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7 (AB)n). The enhancing properties of ThmB can be explained
by stabilization of ThmA through subunit/subunit interactions
and/or participation of ThmB to the pore hydrophilicity (Ser6,
His10, Asn41, and Lys37 in Fig. 7). The proposed model of the
poration complex formed by ThmA and ThmB reminds us of the
acetylcholine receptor channel (35, 36). Finally, The spontane-
ous loss of 18 Da in ThmB is consistent with the cyclization of
the amino-terminal glutamine.
In conclusion, Thermophilin 13 shares functional properties
of lantibiotics and structural properties of, what we propose to
name, type E poration complexes. The prediction of b-turns in
putative loop regions of ThmA, YGNGV-C peptides, and Cur-
vaticin FS47 suggests a structural basis for the interaction of
these peptides with the membranes of Listeria species. Our
model of the poration complex is consistent with the difference
in enhancing properties of ThmB on ThmA and ThmA9. Fi-
nally, the ionophoric activity of Thermophilin 13 in the absence
of a membrane potential, and without the need for a receptor,
makes it an extremely potent compound that differs in its mode
of action from Nisin and other bacteriocins described so far.
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